Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIDOSTAURIN vs MILTEFOSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIDOSTAURIN vs MILTEFOSINE: Safety Overview

Metric MIDOSTAURIN MILTEFOSINE
Total FAERS Reports 2,993 242
Deaths Reported 694 82
Death Rate 23.2% 33.9%
Hospitalizations 918 76
Average Patient Age 53.3 yrs 48.3 yrs
% Female Patients 45.5% 34.4%
FDA Approval Date Apr 28, 2017 Mar 19, 2014
Manufacturer Novartis Pharmaceuticals Corporation Profounda, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription